HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis of cruentaren A.

Abstract
Cruentaren A, an antifungal benzolactone produced by the myxobacterium Byssovorax cruenta, is highly cytotoxic against various human cancer cell lines and a highly selective inhibitor of mitochondrial F-ATPase. A convergent and efficient synthesis of cruentaren A is reported, based upon a diastereoselective alkylation, a series of stereoselective aldol reactions utilizing Myers' pseudoephedrine propionamide, an acyl bromide mediated esterification, and a ring-closing metathesis (RCM) as the key steps. The RCM reaction was applied for the first time toward the total synthesis of cruentaren A, which led to a convergent and efficient synthesis of the natural product.
AuthorsBhaskar Reddy Kusuma, Gary E L Brandt, Brian S J Blagg
JournalOrganic letters (Org Lett) Vol. 14 Issue 24 Pg. 6242-5 (Dec 21 2012) ISSN: 1523-7052 [Electronic] United States
PMID23205851 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifungal Agents
  • Macrolides
  • cruentaren A
  • Mitochondrial Proton-Translocating ATPases
Topics
  • Alkylation
  • Antifungal Agents
  • Humans
  • Macrolides (chemical synthesis, chemistry, pharmacology)
  • Mitochondrial Proton-Translocating ATPases (antagonists & inhibitors)
  • Molecular Structure
  • Myxococcales (chemistry)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: